| Revenue | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 |
| Total Revenue | 35,410,000 | 41,863,000 | 44,294,000 | 45,998,000 |
| Cost of Revenue | 13,256,000 | 16,465,000 | 17,482,000 | 17,889,000 |
| Gross Profit | 22,154,000 | 25,398,000 | 26,812,000 | 28,109,000 |
| Operating Expenses |
| Research Development | - | - | - | - |
| Selling General and Administrative | 12,496,000 | 15,262,000 | 16,427,000 | 17,218,000 |
| Non Recurring | - | - | - | - |
| Others | 48,000 | 274,000 | 145,000 | 24,000 |
| Total Operating Expenses | 25,800,000 | 32,001,000 | 34,054,000 | 35,131,000 |
| Operating Income or Loss | 9,610,000 | 9,862,000 | 10,240,000 | 10,867,000 |
| Income from Continuing Operations |
| Total Other Income/Expenses Net | -2,868,000 | -1,726,000 | -635,000 | -1,542,000 |
| Earnings Before Interest and Taxes | 9,610,000 | 9,862,000 | 10,240,000 | 10,867,000 |
| Interest Expense | -841,000 | -733,000 | -856,000 | -483,000 |
| Income Before Tax | 6,742,000 | 8,136,000 | 9,605,000 | 9,325,000 |
| Income Tax Expense | 5,560,000 | 1,586,000 | 2,239,000 | 2,201,000 |
| Minority Interest | 1,905,000 | 158,000 | 210,000 | 241,000 |
| Net Income From Continuing Ops | 1,182,000 | 6,550,000 | 7,366,000 | 7,124,000 |
| Non-recurring Events |
| Discontinued Operations | 101,000 | 101,000 | 101,000 | 101,000 |
| Extraordinary Items | - | - | - | - |
| Effect Of Accounting Changes | - | - | - | - |
| Other Items | - | - | - | - |
| Net Income |
| Net Income | 1,248,000 | 6,527,000 | 7,351,000 | 7,098,000 |
| Preferred Stock And Other Adjustments | - | - | - | - |
| Net Income Applicable To Common Shares | 1,248,000 | 6,527,000 | 7,351,000 | 7,098,000 |